Biomarkers · Cardiac & Hemodynamics
Galectin-3
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.10per SD (95% CI 1.05–1.14) · Meta-analysis, general population subgroup: 18 studies, n=32,350 participants, ~323,090 person-years, mean age 57.3, median follow-up 5 years
Where people sit
Population percentiles (ng/mL) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 8.03 | 10.5 | 12.6 | 15.2 | 19.8 | 3,353 | Ho JE, Liu C, Lyass A,… |
| All | 40-59 | 9.04 | 11.6 | 13.7 | 16.2 | 20.8 | 3,353 | Ho JE, Liu C, Lyass A,… |
| All | 60+ | 10.2 | 12.8 | 14.9 | 17.5 | 21.9 | 3,353 | Ho JE, Liu C, Lyass A,… |
| All | all | 9.04 | 11.6 | 13.7 | 16.2 | 20.8 | 3,353 | Ho JE, Liu C, Lyass A,… |
| Men | all | 8.79 | 11.1 | 13.1 | 15.4 | 19.5 | 3,353 | Ho JE, Liu C, Lyass A,… |
| Women | all | 9.49 | 12.1 | 14.3 | 16.9 | 21.6 | 3,353 | Ho JE, Liu C, Lyass A,… |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.1 per_sd); per-SD log(HR)=0.095. Reported as per_sd HR=1.1 for all-cause mortality. Random-effects pooled HR per 1-SD increase in galectin-3 for all-cause mortality across 9 general-p
- Imran TF, Shin HJ, Mathenge N, et al. Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population. American Journal of Cardiology. 2017;119(1):57-64.